Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) - Implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism

被引:30
作者
De Martino, MU [1 ]
Alesci, S [1 ]
Chrousos, GP [1 ]
Kino, T [1 ]
机构
[1] NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD 20892 USA
来源
GLUCOCORTICOID ACTION: BASIC AND CLINICAL IMPLICATIONS | 2004年 / 1024卷
关键词
protein-protein interaction; gluconeogenesis; phosphoenol-pyruvate carboxykinase (PEPCK); cholesterol; apolipoproteins; P450CYP7A; xenobiotic metabolism; P450CYP3A;
D O I
10.1196/annals.1321.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Glucocorticoids; exert their extremely diverse effects on numerous biologic activities of humans via only one protein module, the glucocorticoid receptor (GR). The GR binds to the glucocorticoid response elements located in the promoter region of target genes and regulates their transcriptional activity. In addition, GR associates with other transcription factors through direct protein-protein interactions and mutually represses or stimulates each other's transcriptional activities. The latter activity of GR may be more important than the former one, granted that mice harboring a mutant GR, which is active in terms of protein-protein interactions but inactive in terms of transactivation via DNA, survive and procreate, in contrast to mice with a deletion of the entire GR gene that die immediately after birth. We recently found that GR physically interacts with the chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII), which plays a critical role in the metabolism of glucose, cholesterol, and xenobiotics, as well as in the development of the central nervous system in fetus. GR stimulates COUP-TFII-induced transactivation by attracting cofactors via its activation function-1, while COUP-TFII represses the GR-governed transcriptional activity by tethering corepressors, such as the silencing mediator for retinoid and thyroid hormone receptors (SMRT) and the nuclear receptor corepressors (NCoRs) via its C-terminal domain. Their mutual interaction may play an important role in gluconeogenesis, lipoprotein metabolism, and enzymatic clearance of clinically important compounds and bioactive chemicals, by regulating their rate-limiting enzymes and molecules, including the phosphoenolpyruvate carboxykinase (PEPCK), the cytochrome P450 CYP3A and CYP7A, and several apolipoproteins. It appears that glucocorticoids exert their intermediary effects partly via physical interaction with COUP-TFII.
引用
收藏
页码:72 / 85
页数:14
相关论文
共 82 条
[1]   Role of important hydrophobic amino acids in the interaction between the glucocorticoid receptor τ1-core activation domain and target factors [J].
Almlöf, T ;
Wallberg, AE ;
Gustafsson, JÅ ;
Wright, APH .
BIOCHEMISTRY, 1998, 37 (26) :9586-9594
[2]  
[Anonymous], 2001, Endocrinology Metabolism
[3]  
Avigan J, 1977, Expos Annu Biochim Med, V33, P1
[4]   Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids [J].
Bamberger, CM ;
Schulte, HM ;
Chrousos, GP .
ENDOCRINE REVIEWS, 1996, 17 (03) :245-261
[5]   Interaction of steroid hormone receptors with the transcription initiation complex [J].
Beato, M ;
SanchezPacheco, A .
ENDOCRINE REVIEWS, 1996, 17 (06) :587-609
[6]   REGULATORY ELEMENTS AND DNA-BINDING PROTEINS MEDIATING TRANSCRIPTION FROM THE CHICKEN VERY-LOW-DENSITY APOLIPOPROTEIN-II GENE [J].
BEEKMAN, JM ;
WIJNHOLDS, J ;
SCHIPPERS, IJ ;
POT, W ;
GRUBER, M ;
AB, G .
NUCLEIC ACIDS RESEARCH, 1991, 19 (19) :5371-5377
[7]   Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition [J].
Bledsoe, RK ;
Montana, VG ;
Stanley, TB ;
Delves, CJ ;
Apolito, CJ ;
McKee, DD ;
Consler, TG ;
Parks, DJ ;
Stewart, EL ;
Willson, TM ;
Lambert, MH ;
Moore, JT ;
Pearce, KH ;
Xu, HE .
CELL, 2002, 110 (01) :93-105
[8]   AF-2-Dependent potentiation of CCAAT enhancer binding protein β-mediated transcriptional activation by glucocorticoid receptor [J].
Boruk, M ;
Savory, JGA ;
Haché, RJG .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (11) :1749-1763
[9]   GLUCOCORTICOID THERAPY FOR IMMUNE-MEDIATED DISEASES - BASIC AND CLINICAL CORRELATES [J].
BOUMPAS, DT ;
CHROUSOS, GP ;
WILDER, RL ;
CUPPS, TR ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (12) :1198-1208
[10]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388